Apollo Hospitals Chennai performs India’s first adaptive deep brain stimulation for Parkinson’s

Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply

Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses

The device aims to bring precision neuroscience into clinical trials, accelerating drug development

Experts seek insurance coverage for stroke rehabilitation as recovery costs rise

Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes

Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing

The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE

Johnson & Johnson unveils Varipulse Pro in Europe for faster & safer heart procedures

The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect

Alpha Cognition secures key US patent for traumatic brain injury treatment

The patent, titled “ALPHA-1062 for treating Traumatic Brain Injury,” strengthens Alpha Cognition’s existing portfolio supporting both ALPHA-1062 and ZUNVEYL

Amgen’s TEPEZZA injection clears Phase 3 trial with high efficacy

The trial also demonstrated significant improvements across multiple secondary endpoints

HRV Pharma, Shodhana join hands to build next-gen API pipeline for global markets

Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets

Enveric Biosciences bags key US patent for mental health drug

EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes

Nuvation Bio secures global rights to promising brain tumor drug Safusidenib, expands Phase 3 study to Japan